38527-50-3

Basic information

• Product Name: 4H-3,1-Benzoxazin-4-one, 6-Methoxy-2-Methyl-
• Synonyms: 4H-3,1-Benzoxazin-4-one, 6-Methoxy-2-Methyl-;6-methoxy-2-methyl-4H-benzo[d][1,3]oxazin-4-one
• CAS NO: 38527-50-3
• Molecular Formula: C₁₀H₉NO₃
• Molecular Weight: 191.18336
• Mol File: 38527-50-3.mol
• Article Data: 34

Chemical Properties

• Boiling Point: 341.9±44.0 °C(Predicted)
• Appearance: /
• Density: 1.27±0.1 g/cm3(Predicted)
• PKA: 2.41±0.20(Predicted)
• CAS DataBase Reference: 4H-3,1-Benzoxazin-4-one, 6-Methoxy-2-Methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-3,1-Benzoxazin-4-one, 6-Methoxy-2-Methyl-(38527-50-3)
• EPA Substance Registry System: 4H-3,1-Benzoxazin-4-one, 6-Methoxy-2-Methyl-(38527-50-3)

Safety Data

• Hazardous Substances Data: 38527-50-3(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 6705-03-9 2-Amino-5-methoxybenzoic acid 
• 1882-69-5 5-methoxy-2-nitro-benzoic acid 
• 42454-06-8 2-nitro-5-hydroxybenzaldehyde 
• 20357-24-8 5-methoxy-2-nitro-benzaldehyde 
• 100-83-4 meta-hydroxybenzaldehyde 
• 201230-82-2 carbon monoxide 
• 191348-14-8 2-iodo-4-methoxylaniline 

Downstream Products

• 101877-86-5 acetic acid-(4-methoxy-2-o-toluoyl-anilide) 
• 38985-80-7 2-(acetylamino)-5-methoxybenzoic acid 
• 62175-51-3 5-(2-acetylamino-5-methoxy-phenyl)-oxazole-4-carboxylic acid methyl ester 
• 108716-13-8 2-amino-5-methoxy-2'-methyl-benzophenone 
• 166973-19-9 1-[2-amino-5-(methyloxy)phenyl]-2-methyl-1-propanone 
• 880875-40-1 N-[2-(1,3-benzodioxol-5-ylcarbonyl)-4-(methyloxy)phenyl]acetamide 
• 1237744-90-9 4-(6-methoxy-2-methyl-4-oxoquinazolin-3(4H)-yl)benzamide 
• 1237744-94-3 3-(6-methoxy-2-methyl-4-oxoquinazolin-3(4H)-yl)benzoic acid 
• 1237744-75-0 4-(6-methoxy-2-methyl-4-oxoquinazolin-3(4H)-yl)benzoic acid 
• 1237744-89-6 4-(6-methoxy-2-methyl-4-oxoquinazolin-3(4H)-yl)benzonitrile 
• 1237744-91-0 methyl 4-(6-methoxy-2-methyl-4-oxoquinazolin-3(4H)-yl)benzoate 
• 91713-54-1 [2-amino-5-(methyloxy)phenyl](4-chlorophenyl)methanone 
• 1300090-44-1 phenylmethyl (1-(1H-1,2,3-benzotriazol-1-yl)-2-{[2-[(4-chlorophenyl)carbonyl]-4-(methyloxy)phenyl]amino}-2-oxoethyl)carbamate 
• 1300019-48-0 methyl N¹-[2-[(4-chlorophenyl)carbonyl]-4-(methyloxy)phenyl]-N²-{[(9H-fluoren-9-ylmethyl)oxy]carbonyl}-L-α-asparaginate 

Relevant articles and documents

THERAPEUTIC COMPOSITION OF CURE-PRO COMPOUNDS FOR TARGETED DEGRADATION OF BET DOMAIN PROTEINS, AND METHODS OF MAKING AND USAGE

The present application is directed to a therapeutic composition, comprising two precursor compounds (monomers) that are suitable for assembly via two or more reversible covalent bonds. The monomers are polyfunctionalized molecules comprising a bioorthogo

Recyclable palladium-catalyzed carbonylative annulation of 2-iodoanilines with acid anhydrides: A practical synthesis of 2-alkylbenzoxazinones

A highly efficient heterogeneous palladium-catalyzed carbonylative annulation of 2-iodoanilines and acid anhydrides has been developed. The reaction proceeds effectively in toluene using N,N-diisopropylethylamine (DiPEA) as the base at 100 °C under 2 bar of CO and provides a novel, general, and practical method for the assembly of a wide variety of 2-alkylbenzoxazinones with high functional group tolerance and good to excellent yields. This supported palladium complex can be readily separated from the product and recovered by a simple filtration of the reaction solution and reused up to seven times with almost consistent catalytic efficiency.

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

The present disclosure relates to compounds and methods for modulating the expression of dmpk, and treating diseases and conditions in which dmpk plays an active role. The compound can be a transcription modulator molecule having a first terminus, a second terminus, and oligomeric backbone, wherein: a) the first terminus comprises a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CAG or CTG; b) the second terminus comprises a protein-binding moiety binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CAG or CTG; and c) the oligomeric backbone comprising a linker between the first terminus and the second terminus.